Dr. Stanley F. Chalvire is a Registered Patent Attorney, specializing in patent prosecution, licensing of intellectual property and related counseling. Stan focuses his practice on counseling clients in developing and implementing strategies to protect their intellectual property, particularly in the areas relating to small molecule chemistry, pharmaceuticals and biotechnology.
He has experience in matters involving pharmaceutical formulations and drug delivery technologies, genomics, proteins, drug screening and identification, small molecule pharmaceuticals and related methods of treatment.
Before joining MBBP, Stan practiced patent law as intellectual property counsel representing a publicly traded pharmaceutical company. Stan also served as corporate counsel advising the same company on general corporate matters.
Stan has advised clients with respect to patent preparation and prosecution, the evaluation of intellectual property portfolios in association with the licensing of pharmaceutical products from third parties, and counseling his clients with respect to regulatory exclusivity matters. He has advised clients regarding the development and implementation of life cycle management strategies regarding their key products, the preparation of pre-litigation strategies in anticipation of Abbreviated New Drug Applications (ANDA) filings referencing those products and the subsequent representation of the company in Hatch-Waxman patent litigation.
Stan has also supported clients' domestic and international licensing initiatives by conducting in-depth due diligence evaluations and by drafting, negotiating and amending a variety of complex product license, development, supply and distribution agreements.
Prior to beginning his legal career Stan practiced as a Registered Pharmacist in both clinical and retail settings, advising physicians and patients with regard to the optimization of drug therapies, the identification and resolution of drug-drug and drug-disease state interactions, performing prospective and retrospective drug utilization reviews and participating in Pharmacy & Therapeutic Committee meetings at a local teaching hospital.
Stan is a graduate of Massachusetts College of Pharmacy and Health Sciences holding the degrees of Bachelor of Science, Pharmacy and Doctor of Pharmacy. Stan earned his J.D. from Suffolk University Law School, where he successfully completed the Health and Biomedical Law Academic Concentration, focusing his legal studies on matters which are pertinent to clients in the life sciences and biomedical industries.
Pharmaceutical Patent Protection and Enforcement Conference: U.S. Patent Law - Inequitable Conduct and Duty of Candor
2010 MedDev Group: Power of Trade Secrets: When Not To Patent Your Invention
ABC's for Life Sciences Entrepreneurs: From Start-Up to Exit
Former corporate counsel and in-house IP counsel for pharmaceutical company
Massachusetts College of Pharmacy and Health Sciences
Suffolk University Law School
U.S. Patent & Trademark Office
Three Track Patent Examinations: USPTO Provides Further Guidance